Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fuji
Farmers Insurance
Cerilliant
Cantor Fitzgerald
Harvard Business School
US Department of Justice
UBS
Mallinckrodt
Healthtrust
Argus Health

Generated: October 20, 2017

DrugPatentWatch Database Preview

Testolactone - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for testolactone and what is the scope of testolactone freedom to operate?

Testolactone
is the generic ingredient in one branded drug marketed by Bristol Myers Squibb and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are two drug master file entries for testolactone.

Summary for Generic Name: testolactone

US Patents:0
Tradenames:1
Applicants:1
NDAs:2
Drug Master File Entries: see list2
Bulk Api Vendors: see list22
Clinical Trials: see list4
Patent Applications: see list6,097
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:testolactone at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bristol Myers Squibb
TESLAC
testolactone
TABLET;ORAL016118-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Bristol Myers Squibb
TESLAC
testolactone
INJECTABLE;INJECTION016119-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Bristol Myers Squibb
TESLAC
testolactone
TABLET;ORAL016118-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
McKinsey
Express Scripts
Harvard Business School
Medtronic
Mallinckrodt
Chubb
Citi
Colorcon
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot